Position in GRFS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$84,817
-$28,793 QoQ
Shares Held
11,980
-15.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 164 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $230,161,066 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
45,883 | $55,033,445 | |
| 2 | JNJ |
Johnson & Johnson
|
209,661 | $53,247,600 | |
| 3 | ABBV |
AbbVie Inc.
|
108,652 | $27,341,184 | |
| 4 | MRK |
Merck & Co., Inc.
|
209,288 | $26,893,505 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
387,188 | $22,309,767 | |
| 6 | AMGN |
Amgen Inc
|
31,151 | $11,280,394 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
57,490 | $7,263,282 | |
| 8 | PFE |
Pfizer Inc
|
272,103 | $6,552,236 |
All Filings in GRFS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,817 | 11,980 | Shares | Other | 2026-07-20 | |
| 2026-03-31 | $113,610 | 14,166 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $129,636 | 13,865 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $139,219 | 13,978 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $110,740 | 12,250 | Shares | Sole | 2025-07-22 | |
| No filing history on record for this holder in this stock. | ||||||